AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first and only medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide, with more than 150,000 implanted to date. For more information, visit AtriCure.com or follow us on Twitter @AtriCure.
Company’s Keywords:
healthcare, medical devices, manufacturing, atrial fibrillation, maze iv training
920
medical devices
274329000
Mimecast, Outlook, Microsoft Office 365, Microsoft Azure Hosting, Drupal, Adobe Marketing Cloud, Media Temple SSL, Google Tag Manager, YouTube, Akamai RUM, Mobile Friendly, Google Analytics, Signal by BrightTag, SiteScout, Bootstrap Framework, New Relic, Apache, Ubuntu, Typekit
2000